These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 28821472

  • 1. Surgical Findings and Outcomes in Premenopausal Breast Cancer Patients Undergoing Oophorectomy: A Multicenter Review From the Society of Gynecologic Surgeons Fellows Pelvic Research Network.
    Harvey LFB, Abramson VG, Alvarez J, DeStephano C, Hur HC, Lee K, Mattingly P, Park B, Piszczek C, Seifi F, Stuparich M, Yunker A.
    J Minim Invasive Gynecol; 2018 Jan; 25(1):111-115. PubMed ID: 28821472
    [Abstract] [Full Text] [Related]

  • 2. The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.
    Miller H, Pipkin LS, Tung C, Hall TR, Masand RP, Anderson ML.
    J Minim Invasive Gynecol; 2017 Jan; 24(5):772-776. PubMed ID: 28285055
    [Abstract] [Full Text] [Related]

  • 3. Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy.
    Poon C, Hyde S, Grant P, Newman M, Ireland Jenkin K.
    Int J Gynecol Cancer; 2016 Oct; 26(8):1415-20. PubMed ID: 27488216
    [Abstract] [Full Text] [Related]

  • 4. Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices.
    Newcomb LK, Toal CT, Rindos NB, Wang L, Mansuria SM.
    J Minim Invasive Gynecol; 2020 Oct; 27(7):1511-1515. PubMed ID: 31927044
    [Abstract] [Full Text] [Related]

  • 5. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
    Visvanathan K, Shaw P, May BJ, Bahadirli-Talbott A, Kaushiva A, Risch H, Narod S, Wang TL, Parkash V, Vang R, Levine DA, Soslow R, Kurman R, Shih IM.
    Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
    [Abstract] [Full Text] [Related]

  • 6. Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.
    Bogani G, Tagliabue E, Signorelli M, Chiappa V, Carcangiu ML, Paolini B, Casarin J, Scaffa C, Gennaro M, Martinelli F, Borghi C, Ditto A, Lorusso D, Raspagliesi F.
    J Minim Invasive Gynecol; 2017 Nov; 24(5):837-842. PubMed ID: 28479170
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
    Saccardi C, Zovato S, Spagnol G, Bonaldo G, Marchetti M, Alessandrini L, Tognazzo S, Guerriero A, Vitagliano A, Laganà AS, Noventa M.
    Gynecol Oncol; 2021 Nov; 163(2):364-370. PubMed ID: 34465478
    [Abstract] [Full Text] [Related]

  • 8. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
    Mahe E, Tang S, Deb P, Sur M, Lytwyn A, Daya D.
    Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507
    [Abstract] [Full Text] [Related]

  • 9. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R.
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [Abstract] [Full Text] [Related]

  • 10. The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study.
    Gornjec A, Merlo S, Novakovic S, Stegel V, Gazic B, Perhavec A, Blatnik A, Krajc M.
    Radiol Oncol; 2020 May 28; 54(2):180-186. PubMed ID: 32463390
    [Abstract] [Full Text] [Related]

  • 11. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM.
    Am J Obstet Gynecol; 2006 Jun 28; 194(6):1702-9. PubMed ID: 16731090
    [Abstract] [Full Text] [Related]

  • 12. Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists.
    Blustein P, Werner SR, Uppalapati P, Leung TM, Husk GA, Pereira EB, Whyte JS, Villella JA.
    Am J Obstet Gynecol; 2023 Sep 28; 229(3):280.e1-280.e8. PubMed ID: 37308046
    [Abstract] [Full Text] [Related]

  • 13. Incidence of intraepithelial fallopian tube neoplasias in mexican women over 40 years of age that underwent elective hysterectomy.
    Briseño Campos AG, Cruz Rodríguez A, García Perales MO, Serna Vela FJ, Camarillo Elizalde DG, Robles Martínez MDC.
    J Ovarian Res; 2019 Jun 10; 12(1):54. PubMed ID: 31182132
    [Abstract] [Full Text] [Related]

  • 14. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U.
    BJOG; 2011 Jun 10; 118(7):814-24. PubMed ID: 21392246
    [Abstract] [Full Text] [Related]

  • 15. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Aug 10; 33(8):1125-36. PubMed ID: 19440148
    [Abstract] [Full Text] [Related]

  • 16. Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.
    Wilhite AM, Oestreich MC, Olson M, Bedell SM, Westenberg D, Bangdiwala A, Ikramuddin S, Sanchez-Avila M, Madoff RD, Khalifa MA, Erickson BK.
    Obstet Gynecol; 2019 Sep 10; 134(3):520-526. PubMed ID: 31403600
    [Abstract] [Full Text] [Related]

  • 17. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.
    Ayres C, Ratnayake G, McNally O, Quinn M.
    Int J Gynecol Cancer; 2017 May 10; 27(4):703-707. PubMed ID: 28399030
    [Abstract] [Full Text] [Related]

  • 18. Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.
    Samimi G, Trabert B, Duggan MA, Robinson JL, Coa KI, Waibel E, Garcia E, Minasian LM, Sherman ME.
    Gynecol Oncol; 2018 Mar 10; 148(3):515-520. PubMed ID: 29395311
    [Abstract] [Full Text] [Related]

  • 19. Sectioning and extensively examining the fimbriated end (SEE-FIM) of the fallopian tube in routine practices, is it worth the effort?
    Laokulrath N, Warnnissorn M, Chuangsuwanich T, Hanamornroongruang S.
    J Obstet Gynaecol Res; 2019 Mar 10; 45(3):665-670. PubMed ID: 30506766
    [Abstract] [Full Text] [Related]

  • 20. Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
    Rush SK, Swisher EM, Garcia RL, Pennington KP, Agnew KJ, Kilgore MR, Norquist BM.
    Gynecol Oncol; 2020 May 10; 157(2):514-520. PubMed ID: 32199636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.